Innovation Designing for Natural Security [Entire Talk] Andy Karsner, X with Emily Ma, Stanford University Watch Now 48 minutes Video
Strategy The Evolution of Clean Tech Investing [Entire Talk] Amy Francetic, Buoyant Ventures Watch Now 49 minutes Video
Innovation A Needs-Based Innovation Framework [Entire Talk] Kate Rosenbluth, Cala Health Watch Now 49 minutes Video
Josh Makower, MD, Stanford Byers Center for Biodesign The Biodesign Innovation Process [Entire Talk] Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems. × Close Video Clips Josh Makower, MD, Stanford Byers Center for Biodesign The Biodesign Innovation Process [Entire Talk] Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems. Video Clips 2 minutes What is the Biodesign Process? 2 minutes Medical Innovation and Profit 3 minutes Solutions for Rare Conditions 2 minutes Innovating for Health Equity 3 minutes Success and Failure in the Biodesign Process View Video Clips
Josh Makower, MD, Stanford Byers Center for Biodesign The Biodesign Innovation Process Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
Clip 1 of 5 Clip 1 of 5 from: The Biodesign Innovation Process [Entire Talk] Josh Makower, MD, Stanford Byers Center for Biodesign What is the Biodesign Process? Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
Clip 5 of 5 Clip 5 of 5 from: The Biodesign Innovation Process [Entire Talk] Josh Makower, MD, Stanford Byers Center for Biodesign Success and Failure in the Biodesign Process Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
Clip 3 of 5 Clip 3 of 5 from: The Biodesign Innovation Process [Entire Talk] Josh Makower, MD, Stanford Byers Center for Biodesign Solutions for Rare Conditions Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
Clip 4 of 5 Clip 4 of 5 from: The Biodesign Innovation Process [Entire Talk] Josh Makower, MD, Stanford Byers Center for Biodesign Innovating for Health Equity Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
Clip 2 of 5 Clip 2 of 5 from: The Biodesign Innovation Process [Entire Talk] Josh Makower, MD, Stanford Byers Center for Biodesign Medical Innovation and Profit Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
Kristen Fortney, BioAge Labs Derisking Biotech [Entire Talk] Biotech offers huge rewards for founders who approach risk strategically. × Close Video Clips Kristen Fortney, BioAge Labs Derisking Biotech [Entire Talk] Biotech offers huge rewards for founders who approach risk strategically. Video Clips 3 minutes Derisking Milestones in Biotech 2 minutes Bringing New Biotech Treatments to Market 2 minutes Opportunities in Aging and Biotech View Video Clips
Kristen Fortney, BioAge Labs Derisking Biotech Biotech offers huge rewards for founders who approach risk strategically.
Clip 3 of 3 Clip 3 of 3 from: Derisking Biotech [Entire Talk] Kristen Fortney, BioAge Labs Opportunities in Aging and Biotech Biotech offers huge rewards for founders who approach risk strategically.
Clip 1 of 3 Clip 1 of 3 from: Derisking Biotech [Entire Talk] Kristen Fortney, BioAge Labs Derisking Milestones in Biotech Biotech offers huge rewards for founders who approach risk strategically.
Clip 2 of 3 Clip 2 of 3 from: Derisking Biotech [Entire Talk] Kristen Fortney, BioAge Labs Bringing New Biotech Treatments to Market Biotech offers huge rewards for founders who approach risk strategically.
Jorge Rios, Bridgefy Seizing Global Opportunities Discover new opportunities by thinking beyond borders.
Russ Altman, Stanford University Kim Branson, GSK Principled Engineering: AI and Drug Development [Entire Talk] AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks. × Close Video Clips Russ Altman, Stanford University Kim Branson, GSK Principled Engineering: AI and Drug Development [Entire Talk] AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks. Video Clips 3 minutes Ethical Guardrails for AI in Drug Development 3 minutes Ethical Science is Better Science 9 minutes Innovation-Driven Engagement with Regulators 3 minutes Where is AI-Driven Bioengineering Headed Next? View Video Clips
Russ Altman, Stanford University Kim Branson, GSK Principled Engineering: AI and Drug Development AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.
Clip 1 of 4 Clip 1 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk] Russ Altman, Stanford University Kim Branson, GSK Ethical Guardrails for AI in Drug Development AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.
Clip 2 of 4 Clip 2 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk] Russ Altman, Stanford University Kim Branson, GSK Ethical Science is Better Science AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.
Clip 4 of 4 Clip 4 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk] Russ Altman, Stanford University Kim Branson, GSK Where is AI-Driven Bioengineering Headed Next? AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.
Clip 3 of 4 Clip 3 of 4 from: Principled Engineering: AI and Drug Development [Entire Talk] Russ Altman, Stanford University Kim Branson, GSK Innovation-Driven Engagement with Regulators AI-driven bioengineering will draw on past ethical frameworks, but will also require new ethical frameworks.
Paola Santana, GLASS Solving for Infrastructure [Entire Talk] Driving innovation in government and physical infrastructure can be difficult — and rewarding. × Close Video Clips Paola Santana, GLASS Solving for Infrastructure [Entire Talk] Driving innovation in government and physical infrastructure can be difficult — and rewarding. Video Clips 5 minutes Do the Work, then Talk About It 8 minutes Think About the End at the Beginning 5 minutes Why Govtech? 5 minutes Being a Latina Founder in Tech 2 minutes How to Build Productive Relationships with Regulators View Video Clips
Paola Santana, GLASS Solving for Infrastructure Governments might be the largest market that Silicon Valley hasn’t cracked.
Clip 5 of 5 Clip 5 of 5 from: Solving for Infrastructure [Entire Talk] Paola Santana, GLASS How to Build Productive Relationships with Regulators Driving innovation in government and physical infrastructure can be difficult — and rewarding.
Clip 2 of 5 Clip 2 of 5 from: Solving for Infrastructure [Entire Talk] Paola Santana, GLASS Think About the End at the Beginning Driving innovation in government and physical infrastructure can be difficult — and rewarding.
Clip 4 of 5 Clip 4 of 5 from: Solving for Infrastructure [Entire Talk] Paola Santana, GLASS Being a Latina Founder in Tech Driving innovation in government and physical infrastructure can be difficult — and rewarding.